Peringatan Keamanan

Patients experiencing an overdose may present with bleeding.L12141 Treat patients with symptomatic and supportive measures which may include application of local pressure, administration of whole blood or plasma, and administration of aminocaproic acid.L12141

Urokinase

DB00013

biotech approved investigational withdrawn

Deskripsi

Urokinase is an endogenous peptide that is cleaved in the presence of plasmin between lysine 158 and isoleucine 159 to yield active urokinase.A191943 Urokinase remains connected between these 2 chains by a sulfhydryl bond.A191943

Urokinase was granted FDA approval on 16 January 1978.L12138

Struktur Molekul 2D

Struktur tidak tersedia

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) Urokinase has a half life of 12.6±6.2 minutes.[L12138]
Volume Distribusi The volume of distribution of urokinase is 11.5L.[L12138]
Klirens (Clearance) Data regarding the clearance of urokinase is not readily available.

Absorpsi

Urokinase is delivered intravenously, so the bioavailability is high.

Metabolisme

Because urokinase is a protein, it is expected to be metabolized by proteases to smaller proteins and amino acids.

Rute Eliminasi

Urokinase is eliminated in the bile and urine.L12138

Interaksi Makanan

1 Data
  • 1. Avoid herbs and supplements with anticoagulant/antiplatelet activity. Examples include garlic, ginger, bilberry, danshen, piracetam, and ginkgo biloba.

Interaksi Obat

703 Data
Apixaban Apixaban may increase the anticoagulant activities of Urokinase.
Dabigatran etexilate Dabigatran etexilate may increase the anticoagulant activities of Urokinase.
Dasatinib The risk or severity of bleeding and hemorrhage can be increased when Dasatinib is combined with Urokinase.
Deferasirox The risk or severity of gastrointestinal bleeding can be increased when Urokinase is combined with Deferasirox.
Ursodeoxycholic acid The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Ursodeoxycholic acid.
Glycochenodeoxycholic Acid The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Glycochenodeoxycholic Acid.
Cholic Acid The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Cholic Acid.
Glycocholic acid The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Glycocholic acid.
Deoxycholic acid The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Deoxycholic acid.
Taurocholic acid The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Taurocholic acid.
Obeticholic acid The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Obeticholic acid.
Chenodeoxycholic acid The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Chenodeoxycholic acid.
Taurochenodeoxycholic acid The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Taurochenodeoxycholic acid.
Tauroursodeoxycholic acid The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Tauroursodeoxycholic acid.
Bamet-UD2 The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Bamet-UD2.
Dehydrocholic acid The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Dehydrocholic acid.
Hyodeoxycholic Acid The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Hyodeoxycholic Acid.
Edoxaban The risk or severity of bleeding can be increased when Edoxaban is combined with Urokinase.
Ibrutinib The risk or severity of bleeding and hemorrhage can be increased when Ibrutinib is combined with Urokinase.
Obinutuzumab The risk or severity of bleeding and hemorrhage can be increased when Urokinase is combined with Obinutuzumab.
Rivaroxaban Urokinase may increase the anticoagulant activities of Rivaroxaban.
Sugammadex The risk or severity of bleeding and hemorrhage can be increased when Urokinase is combined with Sugammadex.
Tibolone Tibolone may increase the anticoagulant activities of Urokinase.
Tipranavir The risk or severity of bleeding and hemorrhage can be increased when Tipranavir is combined with Urokinase.
Lepirudin Urokinase may increase the anticoagulant activities of Lepirudin.
Bivalirudin Urokinase may increase the anticoagulant activities of Bivalirudin.
Alteplase Urokinase may increase the anticoagulant activities of Alteplase.
Reteplase Urokinase may increase the anticoagulant activities of Reteplase.
Anistreplase Urokinase may increase the anticoagulant activities of Anistreplase.
Tenecteplase Urokinase may increase the anticoagulant activities of Tenecteplase.
Abciximab Urokinase may increase the anticoagulant activities of Abciximab.
Drotrecogin alfa Urokinase may increase the anticoagulant activities of Drotrecogin alfa.
Streptokinase Urokinase may increase the anticoagulant activities of Streptokinase.
Dicoumarol Urokinase may increase the anticoagulant activities of Dicoumarol.
Argatroban Urokinase may increase the anticoagulant activities of Argatroban.
Ardeparin Urokinase may increase the anticoagulant activities of Ardeparin.
Phenindione Urokinase may increase the anticoagulant activities of Phenindione.
Fondaparinux Urokinase may increase the anticoagulant activities of Fondaparinux.
Warfarin Urokinase may increase the anticoagulant activities of Warfarin.
Pentosan polysulfate Urokinase may increase the anticoagulant activities of Pentosan polysulfate.
Phenprocoumon Urokinase may increase the anticoagulant activities of Phenprocoumon.
Dipyridamole Urokinase may increase the anticoagulant activities of Dipyridamole.
Heparin Urokinase may increase the anticoagulant activities of Heparin.
Enoxaparin Urokinase may increase the anticoagulant activities of Enoxaparin.
Epoprostenol Urokinase may increase the anticoagulant activities of Epoprostenol.
Acenocoumarol Urokinase may increase the anticoagulant activities of Acenocoumarol.
4-hydroxycoumarin Urokinase may increase the anticoagulant activities of 4-hydroxycoumarin.
Coumarin Urokinase may increase the anticoagulant activities of Coumarin.
Ximelagatran Urokinase may increase the anticoagulant activities of Ximelagatran.
Desmoteplase Urokinase may increase the anticoagulant activities of Desmoteplase.
Defibrotide Urokinase may increase the anticoagulant activities of Defibrotide.
Ancrod Urokinase may increase the anticoagulant activities of Ancrod.
Beraprost Urokinase may increase the anticoagulant activities of Beraprost.
Prasugrel Urokinase may increase the anticoagulant activities of Prasugrel.
Sulodexide Urokinase may increase the anticoagulant activities of Sulodexide.
Semuloparin Urokinase may increase the anticoagulant activities of Semuloparin.
Idraparinux Urokinase may increase the anticoagulant activities of Idraparinux.
Cangrelor Urokinase may increase the anticoagulant activities of Cangrelor.
Astaxanthin Urokinase may increase the anticoagulant activities of Astaxanthin.
Otamixaban Urokinase may increase the anticoagulant activities of Otamixaban.
Amediplase Urokinase may increase the anticoagulant activities of Amediplase.
Danaparoid Urokinase may increase the anticoagulant activities of Danaparoid.
Dalteparin Urokinase may increase the anticoagulant activities of Dalteparin.
Tinzaparin Urokinase may increase the anticoagulant activities of Tinzaparin.
(R)-warfarin Urokinase may increase the anticoagulant activities of (R)-warfarin.
Ethyl biscoumacetate Urokinase may increase the anticoagulant activities of Ethyl biscoumacetate.
Nadroparin Urokinase may increase the anticoagulant activities of Nadroparin.
Triflusal Urokinase may increase the anticoagulant activities of Triflusal.
Ticagrelor Urokinase may increase the anticoagulant activities of Ticagrelor.
Ditazole Urokinase may increase the anticoagulant activities of Ditazole.
Vorapaxar Urokinase may increase the anticoagulant activities of Vorapaxar.
Sodium citrate Urokinase may increase the anticoagulant activities of Sodium citrate.
Dextran Urokinase may increase the anticoagulant activities of Dextran.
Bemiparin Urokinase may increase the anticoagulant activities of Bemiparin.
Parnaparin Urokinase may increase the anticoagulant activities of Parnaparin.
Desirudin Urokinase may increase the anticoagulant activities of Desirudin.
Antithrombin Alfa Urokinase may increase the anticoagulant activities of Antithrombin Alfa.
Protein C Urokinase may increase the anticoagulant activities of Protein C.
Antithrombin III human Urokinase may increase the anticoagulant activities of Antithrombin III human.
Letaxaban Urokinase may increase the anticoagulant activities of Letaxaban.
Darexaban Urokinase may increase the anticoagulant activities of Darexaban.
Betrixaban Urokinase may increase the anticoagulant activities of Betrixaban.
Nafamostat Urokinase may increase the anticoagulant activities of Nafamostat.
Monteplase Urokinase may increase the anticoagulant activities of Monteplase.
Gabexate Urokinase may increase the anticoagulant activities of Gabexate.
Fluindione Urokinase may increase the anticoagulant activities of Fluindione.
Protein S human Urokinase may increase the anticoagulant activities of Protein S human.
Brinase Urokinase may increase the anticoagulant activities of Brinase.
Clorindione Urokinase may increase the anticoagulant activities of Clorindione.
Diphenadione Urokinase may increase the anticoagulant activities of Diphenadione.
Tioclomarol Urokinase may increase the anticoagulant activities of Tioclomarol.
Melagatran Urokinase may increase the anticoagulant activities of Melagatran.
Saruplase Urokinase may increase the anticoagulant activities of Saruplase.
(S)-Warfarin Urokinase may increase the anticoagulant activities of (S)-Warfarin.
Tocopherylquinone Urokinase may increase the anticoagulant activities of Tocopherylquinone.
Dabigatran Urokinase may increase the anticoagulant activities of Dabigatran.
Edetic acid Urokinase may increase the anticoagulant activities of Edetic acid.
Troxerutin Urokinase may increase the anticoagulant activities of Troxerutin.
Reviparin Urokinase may increase the anticoagulant activities of Reviparin.
Dermatan sulfate Urokinase may increase the anticoagulant activities of Dermatan sulfate.

Target Protein

Plasminogen PLG
Urokinase plasminogen activator surface receptor PLAUR
Plasminogen activator inhibitor 1 SERPINE1
Plasminogen activator inhibitor 2 SERPINB2
Plasma serine protease inhibitor SERPINA5
Low-density lipoprotein receptor-related protein 2 LRP2
Suppressor of tumorigenicity 14 protein ST14
Nidogen-1 NID1

Referensi & Sumber

Synthesis reference: Koji Sasaki, Yasukazu Harada, "Urokinase preparation for oral administration." U.S. Patent US4258030, issued November, 1975.
Artikel (PubMed)
  • PMID: 29779246
    Urano T, Castellino FJ, Suzuki Y: Regulation of plasminogen activation on cell surfaces and fibrin. J Thromb Haemost. 2018 May 20. doi: 10.1111/jth.14157.
  • PMID: 2931434
    Kasai S, Arimura H, Nishida M, Suyama T: Primary structure of single-chain pro-urokinase. J Biol Chem. 1985 Oct 5;260(22):12382-9.

Contoh Produk & Brand

Produk: 3 • International brands: 1
Produk
  • Kinlytic
    Injection, powder, lyophilized, for solution • 250000 [iU]/5mL • Intravenous • US • Approved
  • Kinlytic (urokinase for Injection)
    Powder, for solution • 250000 unit / vial • Intravenous • Canada • Approved
  • Kinlytic Open-cath
    Powder, for solution • 5000 unit / vial • Intravenous • Canada • Approved
International Brands
  • Abbokinase — Abbott Laboratories

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul